Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Farmers Insurance
AstraZeneca
Daiichi Sankyo
Mallinckrodt
Covington
Cerilliant
Harvard Business School
Healthtrust

Generated: December 17, 2018

DrugPatentWatch Database Preview

NEULASTA Drug Profile

« Back to Dashboard

US Patents for NEULASTA

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Amgen NEULASTA pegfilgrastim SYRINGE 125031 001 2002-01-31 ➤ Try a Free Trial Bayer Intellectual Property GMBH (Monheim, DE) ➤ Try a Free Trial RX Orphan search
Amgen NEULASTA pegfilgrastim SYRINGE 125031 001 2002-01-31 ➤ Try a Free Trial Genentech, Inc. (South San Francisco, CA) ➤ Try a Free Trial RX Orphan search
Amgen NEULASTA pegfilgrastim SYRINGE 125031 001 2002-01-31 ➤ Try a Free Trial GENMAB A/S (Copenhagen V, DK) ➤ Try a Free Trial RX Orphan search
Amgen NEULASTA pegfilgrastim SYRINGE 125031 001 2002-01-31 ➤ Try a Free Trial THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK MEMORIAL SLOAN-KETTERING CANCER CENTER (New York, NY) ➤ Try a Free Trial RX Orphan search
Amgen NEULASTA pegfilgrastim SYRINGE 125031 001 2002-01-31 ➤ Try a Free Trial Genentech, Inc. (South San Francisco, CA) ➤ Try a Free Trial RX Orphan search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for NEULASTA

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0106 Netherlands ➤ Try a Free Trial PRODUCT NAME: PEGFILGRASTIM; REGISTRATION NO/DATE: EU/1/02/228/001 20020822
2003 Austria ➤ Try a Free Trial PRODUCT NAME: PEGFILGRASTIM; REGISTRATION NO/DATE: EU/1/02/227/001 20020822
5/2003 Austria ➤ Try a Free Trial PRODUCT NAME: PEGFILGRASTIM
00106 Netherlands ➤ Try a Free Trial PRODUCT NAME: PEGFILGRASTIM; NAT. REGISTRATION NO/DATE: EU/1/02/228/001 20020822; FIRST REGISTRATION: EU/1/02/228/001 20020822
C/GB03/006 United Kingdom ➤ Try a Free Trial PRODUCT NAME: PEGFILGRASTIM, AN N-TERMINALLY MONOPEGYLATED G-CSF (GRANULOCYTE COLONY STIMULATING FACTOR); REGISTERED: UK EU/1/02/228/001 20020826; UK EU/1/02/227/001 20020826
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Fish and Richardson
McKinsey
US Department of Justice
Merck
Cantor Fitzgerald
US Army
Fuji
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.